These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6793685)

  • 21. Binding characteristics of human serum amyloid P component.
    Serban D; Rordorf-Adam C
    Scand J Immunol; 1987 Mar; 25(3):275-81. PubMed ID: 3105045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin binds to amyloid P component. Localization of the binding site to the 31,000 dalton C-terminal domain.
    Rostagno A; Frangione B; Pearlstein E; Garcia-Pardo A
    Biochem Biophys Res Commun; 1986 Oct; 140(1):12-20. PubMed ID: 3778439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of amyloid P protein with pathology in periodontal tissues.
    Short LL; Zoellner H; Hunter N
    J Oral Pathol Med; 1994 Sep; 23(8):354-7. PubMed ID: 7815374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum amyloid P component forms a stable complex with human C5b6.
    Barbashov SF; Wang C; Nicholson-Weller A
    J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin-independent binding of serum amyloid P component to apoptotic cells.
    Familian A; Zwart B; Huisman HG; Rensink I; Roem D; Hordijk PL; Aarden LA; Hack CE
    J Immunol; 2001 Jul; 167(2):647-54. PubMed ID: 11441067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein.
    Christner RB; Mortensen RF
    J Biol Chem; 1994 Apr; 269(13):9760-6. PubMed ID: 8144569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the binding of serum amyloid P to laminin.
    Zahedi K
    J Biol Chem; 1997 Jan; 272(4):2143-8. PubMed ID: 8999915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.
    Kinoshita CM; Gewurz AT; Siegel JN; Ying SC; Hugli TE; Coe JE; Gupta RK; Huckman R; Gewurz H
    Protein Sci; 1992 Jun; 1(6):700-9. PubMed ID: 1304912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct association of fibronectin and actin molecules in vitro.
    Keski-Oja J; Sen A; Todaro GJ
    J Cell Biol; 1980 Jun; 85(3):527-33. PubMed ID: 6893050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephelometric measurement of human serum amyloid P component (SAP).
    Gertz MA; Skinner M; Cohen AS; Kyle RA
    J Lab Clin Med; 1983 Nov; 102(5):773-8. PubMed ID: 6631169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of serum amyloid P component to heparin in human serum.
    Li XA; Hatanaka K; Guo L; Kitamura Y; Yamamoto A
    Biochim Biophys Acta; 1994 Nov; 1201(2):143-8. PubMed ID: 7947925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and characterization of a recombinant C4b-binding protein lacking the beta-chain.
    Härdig Y; García de Frutos P; Dahlbäck B
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):795-800. PubMed ID: 8948435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
    Hohenester E; Hutchinson WL; Pepys MB; Wood SP
    J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.
    Li XA; Yutani C; Shimokado K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum.
    Pepys MB; Butler PJ
    Biochem Biophys Res Commun; 1987 Oct; 148(1):308-13. PubMed ID: 3675579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulphate. An electron microscopic and immunoelectrophoretic study.
    Nielsen EH; Sørensen IJ; Vilsgaard K; Andersen O; Svehag SE
    APMIS; 1994 Jun; 102(6):420-6. PubMed ID: 8068301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels.
    Poulsen ET; Pedersen KW; Marzeda AM; Enghild JJ
    Biochemistry; 2017 Feb; 56(6):896-902. PubMed ID: 28098450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC; Gewurz AT; Jiang H; Gewurz H
    J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.